EUVIMEDEUVIMED entdecken
Open Access

Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users

Nerissa Nance iD, Sylvia E Badon iD, Kathryn Ridout iD, Jennifer Ahern, De-Kun Li iD, Charles Quesenberry, Lyndsay A Avalos iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023

DOI: 10.1002/phar.2790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023. Verfasst von Nerissa Nance und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. Hauptthemen laut MEDLINE: Premature Birth, Pregnancy Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Kaiser Permanente, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little is known about antidepressant medication use patterns during pregnancy among periconception (before and immediately following conception) users. Additionally, the associations between these patterns and birth outcomes is unclear, after taking into account underlying depression severity.

Objective

This study describes patterns of antidepressant use among periconception users and examines associations between usage patterns and birth outcomes. Study Design This retrospective cohort study included pregnant Kaiser Permanente Northern California (KPNC) members with a live birth between 2014 and 2017 and an antidepressant medication fill that overlapped the 8th week of pregnancy. Outcomes were preterm birth and neonatal intensive care unit (NICU) admission. Data were extracted from KPNC's electronic health records. Modified Poisson regression was conducted.

Results

Of the 3637 pregnancies meeting inclusion criteria, 33% ( n = 1204) continued antidepressant use throughout the pregnancy (refilled throughout pregnancy), 47% ( n = 1721) discontinued use (no refills), and 20% ( n = 712) stopped and reinitiated use (refill after 30+ day gap in supply). Women who continued use had 1.86 (95% confidence interval (CI) 1.53, 2.27) times the risk of preterm birth and 1.76 (95% CI: 1.42, 2.19) times the risk of NICU admission, compared to women who discontinued use during pregnancy. Similarly, women with continued use had 1.66 (95% CI: 1.27, 2.18) times the risk of preterm birth and 1.85 (95% CI: 1.39, 2.46) times the risk of NICU admission, compared to women who stopped and reinitiated use. This relationship held when examining continuous exposure; the relationship between continuous exposure and preterm delivery was stronger in later trimesters.

Conclusions

Periconception antidepressant users who continue use during pregnancy, particularly into the second and third trimesters, may be at higher risk of adverse birth outcomes. This evidence should be considered alongside the risks associated with depression relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthPregnancy ComplicationsPregnancyInfant, NewbornFemaleHumansRetrospective StudiesAntidepressive Agents

Stichwörter der Autor:innen

antidepressant medicationanxietymood disordersperinatal depressionpregnancy

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • University of California, Berkeley, Berkeley, California, USA.
  • The Permanente Medical Group, Oakland, California, USA.

ORCID-Profile: Nerissa Nance, Sylvia E Badon, Kathryn Ridout, De-Kun Li, Lyndsay A Avalos

Förderung

  • NICHD NIH HHS
  • Kaiser Permanente
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Nance, N., Badon, S. E., Ridout, K., Ahern, J., Li, D. K., Quesenberry, C., & Avalos, L. A. (2023). Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2790

Vancouver

Nance N, Badon SE, Ridout K, Ahern J, Li DK, Quesenberry C, et al. Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023. doi:10.1002/phar.2790

BibTeX
@article{Nance2023,
  author = {Nance, Nerissa and Badon, Sylvia E and Ridout, Kathryn and Ahern, Jennifer and Li, De-Kun and Quesenberry, Charles and Avalos, Lyndsay A},
  title = {Associations between antidepressant use patterns during pregnancy and birth outcomes among periconception antidepressant users},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2023},
  doi = {10.1002/phar.2790}
}
Kostenlos starten →